Sell to Close your July 17.50 Call Option on Titan Corp. TTN (TTN+GW) at the market.  The stock of defense contractor Titan Corp (TTN) is moving up today handing us a nice gain on our call option. We recommend taking this opportunity to close the position with more than a 30% profit.  Read More

May 17, 2005 Buy to Close your short position in Ford Motor (F) at essentially break even. Read More

Sell to Open Exelon July 45 Put (EXC+SI) at 1.30 or better.  The energy and utility sell-off of the past few days has created quite a few buying opportunities. Our first choice for an aggressive play is utility stock Exelon (EXC). Down from $49 just a week ago,… Read More

Sell to Open CAI September 60 Put (CAI+UL) at the market. We advise aggressive traders to take a leveraged position in CACI International (CAI). The company serves clients in the government and commercial markets information technology (IT) and communications industries. CACI's primary market government IT services remain strong. Read More

May 11, 2005  Sell your Standard & Poor's Depository Receipts (SPY) May 117 call option (SPY+EM) at the market for a loss of 75 percent. Simultaneously buy the July 117 call option (SPY+GM) at the market.   Read More

May 10, 2005  Sell to close your July 60 Simon Property Group put option (SPG+SL) for a 75 percent loss.  We took a short position in Simon Property as a way of playing higher interest rates and weakness in the retail sector.  Read More

May 10, 2005  Buy to Open the Computer Associates June 30 put option (CA+RF); pay no more than $2.80 for the option.   Read More

Sell Short Ford Motors (F) at the market.  Standard & Poor's today lowered its ratings on the debt of Ford to non-investment grade (junk) with negative outlook. The news means that Ford's access to credit and other sources of financing have become much more difficult.  Read More

BUY TO OPEN the August 58 Russell 2000 Growth iShares (IWO) PUT OPTION (IZP+TF) at $3.40 or less.  We advise buying a put on the Russell 2000 Growth Index Fund iShares (IWO) to benefit from what we expect will be a prolonged period of weakness for small-capitalization stocks, in particularly growth stocks which generally sport higher P/E ratios.  Read More

April 29, 2005  Buy Amylin Pharmaceuticals (AMLN) on margin to increase your position in the stock. As expected, the U.S. Food and Drug Administration granted Amylin and its partner Eli Lilly approval to market Amylin's diabetes drug Exenatide (to be sold under the name Byetta).  Read More